An in vivo binding assay to determine central α1-adrenoceptor occupancy using [3H]prazosin-Reference-Cited by-同舟云学术

An in vivo binding assay to determine central α1-adrenoceptor occupancy using [3H]prazosin

Published:2001-12 Issue:3 Volume:8 Page:191-198
ISSN:1385-299X
Container-title:Brain Research Protocols
language:en
Short-container-title:Brain Research Protocols

Author:

Patel Shil,Fernandez-Garcia Eva,Hutson Peter H,Patel Smita

Publisher

Elsevier BV

Subject

General Neuroscience

Reference24 articles.

1. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters;Arnt;Acta Pharmacol. Toxicol.,1984

2. Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for α1 versus α2 and α3 subunit-containing GABAA receptors;Atack;Neuropsychopharmacology,1999

3. Phencyclidine-induced deficits in prepulse inhibition of startle ar blocked by prazosin, an alpha-1 noradrenergic antagonist;Bakshi;J. Pharmacol. Exp. Ther.,1997

4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding;Bradford;Anal. Biochem.,1976

5. In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic in rats;Chaki;Neuropharmacology,1999

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brexpiprazole blocks post-traumatic stress disorder-like memory while promoting normal fear memory;Molecular Psychiatry;2020-08-19

2. Effect of 5-HT 2A and 5-HT 2C receptors on temporal discrimination by mice;Neuropharmacology;2016-08

3. Low-dose prazosin in combination with 5-HT6 antagonist PRX-07034 has antipsychotic effects;Canadian Journal of Physiology and Pharmacology;2015-01

4. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response;Neuropharmacology;2014-02

5. Blockade of MK-801-Induced Heat Shock Protein 72/73 in Rat Brain by Antipsychotic and Monoaminergic Agents Targeting D2, 5-HT_1A, 5-HT_2A and α₁-Adrenergic Receptors;CNS & Neurological Disorders - Drug Targets;2014-02